- Home
- ANY vs RLMD Comparison
ANY vs RLMD Comparison
Compare ANY & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANY
- RLMD
- Stock Information
- Founded
- ANY N/A
- RLMD 2004
- Country
- ANY United States
- RLMD United States
- Employees
- ANY 4
- RLMD N/A
- Industry
- ANY Finance: Consumer Services
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- ANY Finance
- RLMD Health Care
- Exchange
- ANY Nasdaq
- RLMD Nasdaq
- Market Cap
- ANY 22.9M
- RLMD 22.0M
- IPO Year
- ANY N/A
- RLMD N/A
- Fundamental
- Price
- ANY $0.79
- RLMD $0.70
- Analyst Decision
- ANY Strong Buy
- RLMD Hold
- Analyst Count
- ANY 1
- RLMD 4
- Target Price
- ANY $3.00
- RLMD $4.25
- AVG Volume (30 Days)
- ANY 580.1K
- RLMD 851.9K
- Earning Date
- ANY 05-14-2025
- RLMD 05-12-2025
- Dividend Yield
- ANY N/A
- RLMD N/A
- EPS Growth
- ANY N/A
- RLMD N/A
- EPS
- ANY N/A
- RLMD N/A
- Revenue
- ANY $12,479,000.00
- RLMD N/A
- Revenue This Year
- ANY N/A
- RLMD N/A
- Revenue Next Year
- ANY N/A
- RLMD N/A
- P/E Ratio
- ANY N/A
- RLMD N/A
- Revenue Growth
- ANY N/A
- RLMD N/A
- 52 Week Low
- ANY $0.36
- RLMD $0.24
- 52 Week High
- ANY $1.90
- RLMD $4.47
- Technical
- Relative Strength Index (RSI)
- ANY 57.42
- RLMD 64.74
- Support Level
- ANY $0.71
- RLMD $0.66
- Resistance Level
- ANY $0.90
- RLMD $0.77
- Average True Range (ATR)
- ANY 0.09
- RLMD 0.09
- MACD
- ANY -0.01
- RLMD 0.02
- Stochastic Oscillator
- ANY 31.42
- RLMD 81.71
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.